title: Reverse transcription-competitive multiplex PCR improves quantification of mRNA in clinical samples--application to the low abundance CFTR mRNA.
abstract: BACKGROUND
  To monitor gene therapy, we wished to quantify cystic fibrosis transmembrane conductance regulator (CFTR) mRNA. We developed a PCR-based method to measure CFTR mRNA in clinical samples.
  
  
  METHODS
  Expression was determined by reverse transcription-competitive multiplex PCR (RCMP) for CFTR and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts, and for serial dilutions of two internal cDNA standards consisting of CFTR and GAPDH mutants containing short deletions. The RCMP used simultaneous amplification of the gene of interest with a reporter gene in one reaction tube. The expression of CFTR was calculated with reference to the amount of GAPDH to correct for variations in initial RNA loading.
  
  
  RESULTS
  Amplification of cDNAs derived from different amounts of RNA (1-4 microgram) gave similar GAPDH/CFTR ratios, with a coefficient of variation (CV) below 7.5%. RCMP was applied on nasal and bronchial brushings and shows a high variability of CFTR expression in non-cystic fibrosis donors.
  
  
  CONCLUSIONS
  This method is precise and reproducible and advantageous for use with limited amounts of tissue, such as from biopsies or from nasal or bronchial brushings.
authors.affiliation: Department of Internal Medicine, Division of Pulmonary Medicine, and.
authors.forename: S M
authors.initials: SM
authors.lastname: Loitsch
authors.forename: S
authors.initials: S
authors.lastname: Kippenberger
authors.forename: N
authors.initials: N
authors.lastname: Dauletbaev
authors.forename: T O
authors.initials: TO
authors.lastname: Wagner
authors.forename: J
authors.initials: J
authors.lastname: Bargon
mesh_terms: D001980:Bronchi / Q000737:chemistry / Q000166:cytology; D002478:Cells, Cultured; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000032:analysis* / Q000235:genetics; D004587:Electrophoresis, Agar Gel; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000032:analysis / Q000235:genetics; D006801:Humans; D009154:Mutation; D009666:Nose / Q000737:chemistry / Q000166:cytology; D012333:RNA, Messenger / Q000032:analysis*; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity
chemical_list: C505032:CFTR protein, human; D012333:RNA, Messenger; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases